JP2013525440A - 男性の治療のための２−ヒドロキシ−５−フェニルアゾ安息香酸誘導体の製剤および使用 - Google Patents

男性の治療のための２−ヒドロキシ−５−フェニルアゾ安息香酸誘導体の製剤および使用 Download PDF

Info

Publication number
JP2013525440A
JP2013525440A JP2013508147A JP2013508147A JP2013525440A JP 2013525440 A JP2013525440 A JP 2013525440A JP 2013508147 A JP2013508147 A JP 2013508147A JP 2013508147 A JP2013508147 A JP 2013508147A JP 2013525440 A JP2013525440 A JP 2013525440A
Authority
JP
Japan
Prior art keywords
balsalazide
effective amount
therapeutically effective
day
subject
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2013508147A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013525440A5 (enExample
Inventor
ウィリアム フォーブス
エノク ボーティー
ローリン ジョンソン
Original Assignee
サリックス ファーマシューティカルズ リミテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=44861888&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=JP2013525440(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by サリックス ファーマシューティカルズ リミテッド filed Critical サリックス ファーマシューティカルズ リミテッド
Publication of JP2013525440A publication Critical patent/JP2013525440A/ja
Publication of JP2013525440A5 publication Critical patent/JP2013525440A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/655—Azo (—N=N—), diazo (=N2), azoxy (>N—O—N< or N(=O)—N<), azido (—N3) or diazoamino (—N=N—N<) compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
JP2013508147A 2010-04-26 2011-04-26 男性の治療のための２−ヒドロキシ−５−フェニルアゾ安息香酸誘導体の製剤および使用 Pending JP2013525440A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US32815110P 2010-04-26 2010-04-26
US61/328,151 2010-04-26
PCT/US2011/033905 WO2011137103A1 (en) 2010-04-26 2011-04-26 Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives for the treatment of males

Publications (2)

Publication Number Publication Date
JP2013525440A true JP2013525440A (ja) 2013-06-20
JP2013525440A5 JP2013525440A5 (enExample) 2014-06-19

Family

ID=44861888

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013508147A Pending JP2013525440A (ja) 2010-04-26 2011-04-26 男性の治療のための２−ヒドロキシ−５−フェニルアゾ安息香酸誘導体の製剤および使用

Country Status (9)

Country Link
US (3) US8497256B2 (enExample)
EP (1) EP2563117B1 (enExample)
JP (1) JP2013525440A (enExample)
AU (1) AU2011245455A1 (enExample)
BR (2) BR122014009845A2 (enExample)
CA (1) CA2797560A1 (enExample)
IL (1) IL222642A0 (enExample)
MX (1) MX358142B (enExample)
WO (1) WO2011137103A1 (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2021528385A (ja) 2018-06-05 2021-10-21 フラッグシップ パイオニアリング イノベーションズ ブイ， インコーポレイテッド 自己免疫障害を治療するためのアシル化活性剤およびその使用方法

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009506067A (ja) * 2005-08-24 2009-02-12 サリックス ファーマシューティカルズ， インコーポレイテッド バルサラジドの製剤ならびにその製造および使用
JP2010509326A (ja) * 2006-11-03 2010-03-25 サリックス ファーマシューティカルズ， インコーポレイテッド ２−ヒドロキシ−５−フェニル安息香酸誘導体の処方および使用

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US326364A (en) 1885-09-15 Electric-lamp hanger
US4298595A (en) 1978-12-20 1981-11-03 Dynapol Pharmaceutical preparations containing a polymeric agent for releasing 5-aminosalicylic acid or its salts into the gastrointestinal tract
JP2733849B2 (ja) 1987-10-12 1998-03-30 ボロディー，ソーマス・ユリウス 胃腸障害治療のための改良された方法
US5443826A (en) 1988-08-02 1995-08-22 Borody; Thomas J. Treatment of gastro-intestinal disorders with a fecal composition or a composition of bacteroides and E. Coli
US5519014A (en) 1990-10-22 1996-05-21 Borody; Thomas J. Treatment of non-inflammatory and non-infectious bowel disorders
US5498608A (en) 1994-01-07 1996-03-12 Salix Pharmaceuticals Use of 2-hydroxy-5-phenylazobenzoic acid derivatives as colon cancer chemopreventative and chemotherapeutic agents
US5905073A (en) 1995-01-06 1999-05-18 Salix Pharmaceuticals, Inc. Use of 2-hydroxy-5-phenylazobenzoic acid derivatives as colon cancer chemopreventative and chemotherapeutic agents
SE9700934D0 (sv) 1997-03-14 1997-03-14 Astra Ab New formulation
US6551632B2 (en) 1997-04-01 2003-04-22 Thomas Julius Borody Methods and compositions for treating inflammatory bowel disease
CA2285923C (en) 1997-04-01 2013-03-12 Thomas Julius Borody Methods and compositions for treating inflammatory bowel disease
AUPO665397A0 (en) 1997-05-07 1997-05-29 Borody, Thomas Julius Novel therapy for constipation
AUPP437698A0 (en) 1998-06-30 1998-07-23 Baumgart, Karl Methods for treatment of coronary, carotid and other vascular disease
US6326364B1 (en) 1999-02-08 2001-12-04 Cedars-Sinai Medical Center Use of 5-aminosalicylates as antimicrobial agents
US7452872B2 (en) * 2005-08-24 2008-11-18 Salix Pharmaceuticals, Inc. Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives
WO2008033125A1 (en) 2006-09-13 2008-03-20 The Procter & Gamble Company Methods of treatment for ulcerative colitis using aminosalicylate

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009506067A (ja) * 2005-08-24 2009-02-12 サリックス ファーマシューティカルズ， インコーポレイテッド バルサラジドの製剤ならびにその製造および使用
JP2010509326A (ja) * 2006-11-03 2010-03-25 サリックス ファーマシューティカルズ， インコーポレイテッド ２−ヒドロキシ−５−フェニル安息香酸誘導体の処方および使用

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
JPN5013006910; ＡＬＥＸＡＮＤＥＲ: 'ＤＩＧＥＳＴＩＶＥ　ＤＩＳＥＡＳＥ　ＷＥＥＫ　ＡＮＤ　ＡＭＥＲＩＣＡＮ　ＤＩＡＢＥＴＥＳ　ＡＳＳＯＣＩＡＴＩＯＮ' ＰＨＡＲＭＡＣＥＹ　ＡＮＤ　ＴＨＥＲＡＰＥＵＴＩＣＳ Ｖ３３　Ｎ９, 2008, Ｐ５４６-５４９ *

Also Published As

Publication number Publication date
BR122014009845A2 (pt) 2015-12-29
BR112012027520A2 (pt) 2015-09-15
US8497256B2 (en) 2013-07-30
EP2563117B1 (en) 2018-02-21
EP2563117A1 (en) 2013-03-06
IL222642A0 (en) 2012-12-31
MX358142B (es) 2018-08-06
CA2797560A1 (en) 2011-11-03
EP2563117A4 (en) 2013-09-04
MX2012012324A (es) 2013-01-29
AU2011245455A1 (en) 2012-11-15
US20120058184A1 (en) 2012-03-08
US20130295178A1 (en) 2013-11-07
WO2011137103A1 (en) 2011-11-03
US20150132381A1 (en) 2015-05-14

Similar Documents

Publication Publication Date Title
JP6067203B2 (ja) ２−ヒドロキシ−５−フェニル安息香酸誘導体の処方および使用
US7625884B2 (en) Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives
KR20150132214A (ko) 방사선 직장ｓ상결장염의 치료를 위한 조성물 및 방법
WO2008122190A1 (en) The composition comprising l-carnitine or derivatives thereof and its use
TW202114671A (zh) 包含fxr促效劑之治療
TW202114654A (zh) 包含如sglt 1/2抑制劑的sglt抑制劑之治療
EP2563117B1 (en) Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives for the treatment of males
JP6027799B2 (ja) 頻尿治療用組成物
HK1182590B (en) Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives for the treatment of males
HK1182590A (en) Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives for the treatment of males
AU2013228061B2 (en) Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives
CN119280196A (zh) 一种含伐地那非的口溶膜组合物及其应用
JP2006117569A (ja) ステロイド依存性あるいはステロイド抵抗性潰瘍性大腸炎治療薬
HK1134221B (en) Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives
HK1134221A (en) Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives
WO2016171656A1 (en) Formulations containing diacerein and methods of lowering blood levels of uric acid using the same

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20140421

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20140421

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20150121

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20150123

RD04 Notification of resignation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7424

Effective date: 20150415

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20150420

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20150930